A Randomized, Double-blind, Multi-center, Phase III Study of AK112 or Placebo Combined with Pemetrexed and Carboplatin in Patients with EGFR-mutant Locally Advanced or Metastatic Non-squamous NSCLC Who Have Failed to EGFR-TKI Treatment (HARMONi)

by | Jul 3, 2024 | Clinical Trials, Ensayos Clínicos - CIMO-02 | 0 comments

MANUEL COBO DOLS – ENSAYO CLÍNICO CON MEDICAMENTOS – SUMMIT THERAPEUTICS, INC.